These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18189292)

  • 21. Prognostic factors and outcomes in 28 cases of uterine leiomyosarcoma.
    Loizzi V; Cormio G; Nestola D; Falagario M; Surgo A; Camporeale A; Putignano G; Selvaggi L
    Oncology; 2011; 81(2):91-7. PubMed ID: 21968290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis.
    Bregar AJ; Alejandro Rauh-Hain J; Spencer R; Clemmer JT; Schorge JO; Rice LW; Del Carmen MG
    Gynecol Oncol; 2017 Apr; 145(1):114-121. PubMed ID: 28159409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Black race independently predicts worse survival in uterine carcinosarcoma.
    Erickson BK; Doo DW; Zhang B; Huh WK; Leath CA
    Gynecol Oncol; 2014 May; 133(2):238-41. PubMed ID: 24613675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma.
    Casarin J; Bogani G; Piovano E; Falcone F; Ferrari F; Odicino F; Puppo A; Bonfiglio F; Donadello N; Pinelli C; Laganà AS; Ditto A; Malzoni M; Greggi S; Raspagliesi F; Ghezzi F
    J Gynecol Oncol; 2020 Sep; 31(5):e64. PubMed ID: 32808495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymph node dissection in uterine leiomyosarcomas: A matched-pair study.
    Coronado PJ; Alonso-Espias M; Yildirim Y; Macuks R; Mancari R; Achimas-Cadariu P; Aniorte SM; Mitidieri M; Lambaudie E; Dubois N; Zapardiel I;
    Gynecol Oncol; 2023 Jul; 174():28-33. PubMed ID: 37146437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The outcomes of 27,063 women with unstaged endometrioid uterine cancer.
    Chan JK; Wu H; Cheung MK; Shin JY; Osann K; Kapp DS
    Gynecol Oncol; 2007 Aug; 106(2):282-8. PubMed ID: 17662377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
    Wang J; Li J; Chen R; Lu X
    Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multi-institutional study of pancreatic cancer in Harris County, Texas: race predicts treatment and survival.
    Wray CJ; Castro-Echeverry E; Silberfein EJ; Ko TC; Kao LS
    Ann Surg Oncol; 2012 Sep; 19(9):2776-81. PubMed ID: 22526908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation therapy improves disease-specific survival in women with Stage II endometrioid endometrial cancer-Brachytherapy may be sufficient.
    Nwachukwu CR; Von-Eyben R; Kidd EA
    Brachytherapy; 2018; 17(2):383-391. PubMed ID: 29198879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial disparities in outcomes for high-grade uterine cancer: A California cancer registry study.
    Baskovic M; Lichtensztajn DY; Nguyen T; Karam A; English DP
    Cancer Med; 2018 Sep; 7(9):4485-4495. PubMed ID: 30123978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types.
    Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
    JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma.
    Giuntoli RL; Lessard-Anderson CR; Gerardi MA; Kushnir CL; Cliby WA; Metzinger DS; Gostout BS
    Int J Gynecol Cancer; 2013 Jun; 23(5):869-76. PubMed ID: 23669444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of lymphadenectomy in uterine endometrioid carcinoma.
    Huang CY; Ho CM; Chen YL; You SL; Chen CA; Cheng WF
    Eur J Surg Oncol; 2013 Apr; 39(4):350-7. PubMed ID: 23462243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis.
    Nemani D; Mitra N; Guo M; Lin L
    Gynecol Oncol; 2008 Oct; 111(1):82-8. PubMed ID: 18674808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does Lymphadenectomy Improve Survival in Uterine Leiomyosarcoma?
    Tasci T; Karalok A; Taskin S; Ureyen I; Kımyon G; Tulek F; Ozfuttu A; Turan T; Tulunay G; Kose MF; Ortac F
    Int J Gynecol Cancer; 2015 Jul; 25(6):1031-6. PubMed ID: 25853382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial disparities in high-risk uterine cancer histologic subtypes: A United States Cancer Statistics study.
    Abel MK; Liao CI; Chan C; Lee D; Rohatgi A; Darcy KM; Tian C; Mann AK; Maxwell GL; Kapp DS; Chan JK
    Gynecol Oncol; 2021 May; 161(2):470-476. PubMed ID: 33722415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.
    Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
    JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment Outcomes.
    Nathenson MJ; Conley AP; Lin H; Fleming N; Lazar A; Wang WL; Ravi V
    Int J Gynecol Cancer; 2018 Sep; 28(7):1297-1310. PubMed ID: 30044322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease-specific survival after radical lymphadenectomy for penile cancer: prediction by lymph node count and density.
    Li ZS; Yao K; Chen P; Zou ZJ; Qin ZK; Liu ZW; Li YH; Zhou FJ; Han H
    Urol Oncol; 2014 Aug; 32(6):893-900. PubMed ID: 24994488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.